SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001384101-22-000004
Filing Date
2022-01-11
Accepted
2022-01-11 16:50:30
Documents
12
Period of Report
2022-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20220106.htm   iXBRL 8-K 38311
  Complete submission text file 0001384101-22-000004.txt   181079

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20220106.xsd EX-101.SCH 1927
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20220106_lab.xml EX-101.LAB 25298
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20220106_pre.xml EX-101.PRE 13202
6 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20220106_htm.xml XML 12391
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 22524495
SIC: 8071 Services-Medical Laboratories